Matsubara Masahiro, Tamura Tadafumi, Ohmori Kenji, Hasegawa Kazuhide
Department of Pharmacology and Molecular Biology, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co. Ltd., Shizuoka 411-8731, Japan.
Biochem Pharmacol. 2005 Feb 1;69(3):433-49. doi: 10.1016/j.bcp.2004.10.006. Epub 2004 Dec 9.
Histamine H1 receptor (H1R), a therapeutic target for alleviation of acute allergic reaction, may be also involved in mediating inflammatory responses via effects on cytokine production. However, the mechanisms whereby histamine induces cytokine production are poorly defined. In this study, we comprehensively investigated the signaling pathway involved in cytokine expression caused by histamine, using native human epidermal keratinocytes. We confirmed the expression of functional H1R by reverse transcription-polymerase chain reaction (RT-PCR), Western blotting and histamine-induced Ca(2+) elevation. Histamine induced concentration- and time-dependent production of granulocyte-macrophage-colony stimulating factor (GM-CSF), interleukin (IL)-8 and IL-6, which was completely blocked by olopatadine, an H1 antagonist. Histamine activated the phosphorylation of protein kinase C (PKC), c-Raf, mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), I kappa B kinase (IKK), inhibitory kappa B (I kappa B)-alpha and nuclear factor-KB (NF-kappa B) p65, which was inhibited by Ro-31-8220, a PKC inhibitor. Also, Ro-31-8220 significantly suppressed the expression of these cytokines. BAPTA-AM, an intracellular Ca(2+) chelator, also reduced PKC phosphorylation and cytokine expression. PD98059, a MEK inhibitor, and BAY 11-8702, an I kappa B-alpha inhibitor, reduced ERK and NF-kappa B cascade activation, respectively, with little effect on PKC phosphorylation. PD98059 preferentially inhibited GM-CSF production whereas BAY 11-8702 prevented IL-8 and IL-6 production. Furthermore, in addition to the above cytokines, histamine stimulated the biosynthesis and/or release of numerous keratinocyte-derived mediators, which are probably regulated by the ERK or NF-kappa B cascades. Our study suggests that histamine activates Ca(2+)-dependent PKC isoforms that play crucial roles in the activation of Raf/MEK/ERK and IKK/I kappa B/NF-kappa B cascades, leading to up-regulation of cytokine expression. Thus, the anti-inflammatory benefit of H1 antagonists may be in part due to prevention of cytokine production.
组胺H1受体(H1R)是缓解急性过敏反应的治疗靶点,也可能通过影响细胞因子产生来介导炎症反应。然而,组胺诱导细胞因子产生的机制尚不清楚。在本研究中,我们使用原代人表皮角质形成细胞全面研究了组胺引起的细胞因子表达所涉及的信号通路。我们通过逆转录聚合酶链反应(RT-PCR)、蛋白质印迹法和组胺诱导的Ca(2+)升高证实了功能性H1R的表达。组胺诱导粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素(IL)-8和IL-6的浓度和时间依赖性产生,这被H1拮抗剂奥洛他定完全阻断。组胺激活蛋白激酶C(PKC)、c-Raf、丝裂原活化蛋白/细胞外信号调节激酶激酶(MEK)、细胞外信号调节激酶(ERK)、IκB激酶(IKK)、抑制性κB(IκB)-α和核因子-κB(NF-κB)p65的磷酸化,这被PKC抑制剂Ro-31-8220抑制。此外,Ro-31-8220显著抑制这些细胞因子的表达。细胞内Ca(2+)螯合剂BAPTA-AM也降低了PKC磷酸化和细胞因子表达。MEK抑制剂PD98059和IκB-α抑制剂BAY 11-8702分别降低了ERK和NF-κB级联激活,对PKC磷酸化影响很小。PD98059优先抑制GM-CSF产生,而BAY 11-8702阻止IL-8和IL-6产生。此外,除了上述细胞因子外,组胺还刺激了多种角质形成细胞衍生介质的生物合成和/或释放,这些介质可能受ERK或NF-κB级联调节。我们的研究表明,组胺激活Ca(2+)依赖性PKC同工型,其在Raf/MEK/ERK和IKK/IκB/NF-κB级联激活中起关键作用,导致细胞因子表达上调。因此,H1拮抗剂的抗炎益处可能部分归因于预防细胞因子产生。